Skip to main content

Day: September 4, 2024

Cross Keys Capital Advises Illinois CancerCare in Its Strategic Relationship with The US Oncology Network

Fort Lauderdale, Sept. 04, 2024 (GLOBE NEWSWIRE) — Cross Keys Capital, a leading independent investment banking firm providing M&A advisory services to physician group practices and healthcare services companies, is pleased to announce it acted as the exclusive financial advisor to Illinois CancerCare (ILCC) in its strategic relationship with The US Oncology Network (The Network). ILCC has 14 sites of service located throughout the Central Illinois market. ILCC’s 21 physicians and 37 advanced practice providers offer medical oncology and hematology care in addition to a variety of ancillary services including specialty retail pharmacy, genetic testing, imaging, research, and clinical trials. ILCC is the largest independent oncology practice in the Midwest United States and is led by its President, Paul Fishkin, MD, and Executive...

Continue reading

GDEV announces unaudited results for the second quarter and first half of 2024

LIMASSOL, Cyprus, Sept. 04, 2024 (GLOBE NEWSWIRE) — GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”) released its unaudited financial and operational results for the second quarter and first half-year ended June 30, 2024. GDEV CEO, Andrey Fadeev stated: “Over the past months, we’ve been refining our strategic vision, and now we’re prepared to push forward with renewed confidence. Despite the temporary decline in some of our key operational and financial metrics, our ability to maintain a robust revenue mix between PC and mobile platforms — where PC has grown to 42% of our total bookings — underscores our adaptive strategy and resilience. Additionally, our strong cash flow trends, the significant reduction in platform commissions and the reduction of the game operation...

Continue reading

The Saudi Food and Drug Authority (SFDA) Approves Biomerica’s At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

– 10-Minute At-Home PSA Test for Early Detection of Prostate Cancer – First order already shipped to Saudi Arabia – Prostate Cancer is the Second Most Common Cancer in Men Globally IRVINE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA) is pleased to announce that the Saudi Food and Drug Authority (SFDA) has approved the Company’s Fortel® Prostate (PSA) Screening Test to be sold and used in the country. This at-home test is designed to empower men with the ability to detect early warning signs of prostate cancer from the comfort of their own homes. The Fortel® Prostate (PSA) At-Home Screening Test is a user-friendly, rapid diagnostic tool that measures elevated PSA, an early indicator of prostate disease, including cancer. Utilizing a simple finger-prick blood sample, the test delivers...

Continue reading

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SCOTTSDALE, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 26th Annual Global Investment Conference. The presentation will be available for on-demand viewing by conference attendees starting on September 9, 2024, at 7:00 a.m. ET. The Company will also attend one-on-one meetings during the conference. A replay of the presentation will be available shortly after the conference on the News and Events...

Continue reading

America’s Car-Mart Reports First Quarter Fiscal Year 2025 Results

ROGERS, Ark., Sept. 04, 2024 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today reported financial results for the first quarter ended July 31, 2024. First Quarter Key Highlights (FY’25 vs. FY’24 Q1, unless otherwise noted)Revenue was $347.8 million, down 5.2% Interest income increased $4.1 million, up 7.2% Total collections increased 4.3% to $172.9 million Favorable adjustment to allowance for credit loss to 25.0%, down from 25.32% Net charge-offs as a % of average finance receivables were 6.4% vs. 5.8% Interest expense increased $4.0 million, or 28.3% Loss per share of $0.15 vs. diluted earnings per share of $0.63President and CEO Doug Campbell commentary: “I’m encouraged with our rebound in sales volume from two quarters ago, despite the ongoing economic challenges...

Continue reading

Daktronics, Inc. Announces 2025 Fiscal First Quarter Results

Solid Sequential GAAP Revenue Growth, Margin Expansion, and Cash Flow Generation Earned $22.7 Million of Operating Income and Adjusted Net Income(1) of $16.6 Million BROOKINGS, S.D., Sept. 04, 2024 (GLOBE NEWSWIRE) — Daktronics, Inc. (NASDAQ-DAKT), the leading U.S.-based designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide, today reported results for its fiscal 2025 first quarter which ended July 27, 2024. Fiscal Q1 2025 financial highlights:Sales of $226.1 million, a 4.7 percent sequential increase from the fourth quarter of fiscal 2024, aligning with expected seasonal demand and driven by increased production and deliveries for sports and outdoor related seasonal business Gross profit as a percentage of net sales of 26.4 percent as compared to 25.7 percent...

Continue reading

Osisko Provides Select Asset Updates

MONTRÉAL, Sept. 04, 2024 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (OR: TSX & NYSE) is pleased to provide some select asset updates. Jason Attew, President & CEO of Osisko commented: “Over the past few months, Osisko’s asset base provided for some positive developments that have surfaced incremental value for the Company, with more portfolio catalysts expected between now and end-of-year 2024. In the meantime, much of Osisko’s short-to-medium-term growth continues to be underpinned by several advanced projects including three shafts currently under construction at Odyssey Underground, the Island Gold District, and Hermosa/Taylor, along with two open pits at, or nearing, the final stages of development at Tocantinzinho and Namdini, respectively.” Note: all amounts included in this update...

Continue reading

Berkshire Grey Announces Formal Partnership with Kardex; Powering Robotic Picking From an AutoStore

BEDFORD, Ma., Sept. 04, 2024 (GLOBE NEWSWIRE) — Berkshire Grey Inc., a well-established leader in AI-enabled robotic solutions that automate supply chain processes, announces the signing of a global partnership agreement with Kardex AS Solutions. Kardex is a global industry provider of intralogistics solutions and automated storage solutions and is the fastest growing AutoStore provider. This partnership will establish Berkshire Grey as a key provider of AI-enabled robotic picking for customers utilizing AutoStore empowered by Kardex. Key Benefits of the Combined Solutions:One Touch Fulfillment: With 99.99% picking accuracy, confidently pick, pack, and ship orders to customers without manual verification, significantly improving operational efficiency. Integrated Fulfillment Solution: A fully integrated, end-to-end automated...

Continue reading

GoHealth Acquiring e-TeleQuote, Strengthening Position as Leading Medicare Insurance Marketplace

Investment further expands industry-leading shopping, enrollment, and engagement platform, delivering a differentiated experience and driving high quality outcomes while ensuring peace of mind in Medicare consumers’ healthcare decisions CHICAGO and CLEARWATER, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) — GoHealth, Inc. (Nasdaq: GOCO), a leading health insurance marketplace, today announced that it entered into a purchase and subscription agreement which will ultimately lead to the acquisition of e-TeleQuote Insurance, Inc., a distinguished name in the Medicare insurance marketplace. The transaction is expected to close on September 30, 2024. This strategic move represents a significant milestone in GoHealth’s mission to deliver unparalleled consumer-centric solutions while reinforcing the companies’ shared values of integrity, empathy,...

Continue reading

Whitestone REIT Declares Fourth Quarter 2024 Dividend

HOUSTON, Sept. 04, 2024 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a monthly cash dividend of $0.04125 per share on the Company’s common shares and operating partnership units for the fourth quarter of 2024. The dividend represents a quarterly amount of $0.12375 per share, and an annualized amount of $0.495 per share. The fourth quarter dividend distribution for 2024 will be as detailed below:Month Record Date Payment Date Distribution perShare/UnitOctober 10/2/2024 10/10/2024 $0.04125November 11/4/2024 11/14/2024 $0.04125December 12/3/2024 12/12/2024 $0.04125About Whitestone REIT Whitestone REIT (NYSE: WSR) is a community-centered real estate investment trust (REIT) that acquires, owns, operates, and develops open-air,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.